Lishan Aklog
CIK: 0001665074
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Aklog Lishan
Aklog Lishan (SEC CIK 0001665074) files insider reports with the SEC as Chairman and CEO of PAVmed Inc. (PAVM) and Chief Executive Officer of Lucid Diagnostics Inc. (LUCD).
Signal8 holds 4 ownership filings by Aklog Lishan, all Form 4s, filed between Feb 21, 2025 and Apr 3, 2026. Those filings report 4 transactions, from Feb 20, 2025 to Apr 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aklog Lishan's filings is in NEW YORK, NY.
Recent filings by Aklog Lishan
Other insiders filing for PAVmed Inc. (PAVM)
- Lee Victoria Tou-ho, Chief Medical Officer
- Tasso Partners, LLC, 10% Owner
- MCGRATH DENNIS M, President and CFO
- Glennon Michael J, Director
- Baxter Timothy E, Director
- White Debra, Director